Kidney-infiltrating CD4 T-cell clones promote nephritis in lupus-prone mice

Kidney International

Volumn 82, Issue 9, 2012, Pages 969-979

  Okamoto, Akiko ^a   Fujio, Keishi ^a   Tsuno, Nelson H ^a   Takahashi, Koki ^a   Yamamoto, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

glomerulonephritis; immunology and pathology; lupus nephritis

Indexed keywords

DNA ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE 2ALPHA; MIXED LINEAGE KINASE 2BETA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; IMMUNOREACTIVITY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TH1 CELL;

EID: 84867512198     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.242     Document Type: Article

References (46)

1. William J, Euler C, Christensen S. et al. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002; 297: 2066-2070
2. Wellmann U, Letz M, Herrmann M. et al. The evolution of human antidouble-stranded DNA autoantibodies. Proc Natl Acad Sci USA 2005; 102: 9258-9263
3. Mohan C, Adams S, Stanik V. et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-1381
4. Monneaux F, Hoebeke J, Sordet C. et al. Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J Immunol 2005; 175: 5839-5847
5. Talken BL, Holyst MM, Lee DR. et al. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Arthritis Rheum 1999; 42: 703-709
6. Adams S, Leblanc P, Datta SK. Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens. Proc Natl Acad Sci USA 1991; 88: 11271-11275
7. Bagavant H, Fu SM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 2009; 21: 489-494
8. Chan OT, Hannum LG, Haberman AM. et al. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189: 1639-1648
9. Schiffer L, Sinha J, Wang X. et al. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003; 171: 489-497
10. Bagavant H, Deshmukh US, Wang H. et al. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol 2006; 177: 8258-8265
11. Haas C, Ryffel B, Le Hir M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol 1997; 158: 5484-5491
12. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998; 101: 364-371
13. Schwarting A, Wada T, Kinoshita K. et al. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 1998; 161: 494-503
14. Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987; 166: 798-803
15. Ozmen L, Roman D, Fountoulakis M. et al. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25: 6-12
16. Akahoshi M, Nakashima H, Tanaka Y. et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1644-1648
17. Masutani K, Akahoshi M, Tsuruya K. et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 2001; 44: 2097-2106
18. Nakashima H, Inoue H, Akahoshi M. et al. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 1999; 453: 187-190
19. Miyake K, Nakashima H, Akahoshi M. et al. Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology (Oxford) 2002; 41: 518-524
20. Azzam HS, Grinberg A, Lui K. et al. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 1998; 188: 2301-2311
21. Kassiotis G, Zamoyska R, Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med 2003; 197: 1007-1016
22. Boesteanu A, Rankin AL, Caton AJ. Impact of effector cell differentiation on CD4+ T cells that evade negative selection by a self-peptide. Int Immunol 2006; 18: 1017-1027
23. Carrera AC, Cardenas L, Tugores A. et al. Activators of protein kinase C upregulate the cell surface expression of CD2 and CD5 T cell glycoproteins. J Biol Chem 1989; 264: 15650-15655
24. Lozano F, Alberola-Ila J, Places L. et al. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells. Immunology 1990; 70: 434-439
25. Yamamoto K, Sakoda H, Nakajima T. et al. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 1992; 4: 1219-1223
26. Tahara H, Fujio K, Araki Y. et al. Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte. J Immunol 2003; 171: 2154-2160
27. Lathrop SK, Bloom SM, Rao SM. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478: 250-254
28. Fujio K, Okamoto A, Tahara H. et al. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J Immunol 2004; 173: 2118-2125
29. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969
30. Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol 2003; 170: 3915-3925
31. Tesch GH, Maifert S, Schwarting A. et al. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 1999; 190: 1813-1824
32. Kawakami N, Lassmann S, Li Z. et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 2004; 199: 185-197
33. Cassatella MA, Bazzoni F, Calzetti F. et al. Interferon-gamma transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human polymorphonuclear leukocytes. J Biol Chem 1991; 266: 22079-22082
34. Gold DP, Offner H, Sun D. et al. Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J Exp Med 1991; 174: 1467-1476
35. Osman GE, Toda M, Kanagawa O. et al. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J Exp Med 1993; 177: 387-395
36. Nakajima A, Seroogy CM, Sandora MR. et al. Antigen-specific T cellmediated gene therapy in collagen-induced arthritis. J Clin Invest 2001; 107: 1293-1301
37. Costa GL, Sandora MR, Nakajima A. et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 2001; 167: 2379-2387
38. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063-1066
39. Fujio K, Okamoto A, Araki Y. et al. Gene therapy of arthritis with TCR isolated from the inflamed paw. J Immunol 2006; 177: 8140-8147
40. Okamoto A, Fujio K, van Rooijen N. et al. Splenic phagocytes promote responses to nucleosomes in (NZB x NZW) F1 mice. J Immunol 2008; 181: 5264-5271
41. Kamme F, Salunga R, Yu J. et al. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J Neurosci 2003; 23: 3607-3615
42. Yamamoto K, Masuko-Hongo K, Tanaka A. et al. Establishment and application of a novel T cell clonality analysis using single-strand conformation polymorphism of T cell receptor messenger signals. Hum Immunol 1996; 48: 23-31
43. Fujio K, Misaki Y, Setoguchi K. et al. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J Immunol 2000; 165: 528-532
44. Inoue A, Hasegawa H, Kohno M. et al. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 2005; 52: 1522-1533
45. Muraoka M, Hasegawa H, Kohno M. et al. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 2006; 54: 3591-3600
46. Pawar RD, Patole PS, Ellwart A. et al. Ligands to nucleic acid-specific Tolllike receptors and the onset of lupus nephritis. J Am Soc Nephrol 2006; 17: 3365-3373.